Barring a huge meltdown, the S&P 500 will once again have a double-digit year of gains, and most investors should be looking at their 401(k)s and other accounts with some…

Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales. Source: BioSpace

In an analysis of BMS' recent clinical history, Industry analysts at Trefis noted that two oncology drugs will be key revenue drivers for the company. Source: BioSpace

Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013. Source: BioSpace

There are some changes taking place in the C-suites at Shire. Source: BioSpace

HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans. Source: BioSpace

Foundation Medicine's sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday. Source: BioSpace

The spike began after the six-person company announced it had entered into a multi-year services agreement with Merck KGaA. Source: BioSpace

An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths. Source: BioSpace

These great biotech stocks to buy for the holidays come in all sizes -- small-cap, mid-cap, and large-cap. Source: BioSpace